Phase 3 ADHD Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have been officially diagnosed with ADHD (and not a vague or unclear form of it) based on standard diagnostic guidelines, confirmed through a structured interview.
- Your ADHD symptoms score at least 28 out of a possible total on a standard rating scale at the start of the trial (called "baseline"), or at least 22 if you are already taking ADHD medication — measured during an earlier screening visit.
- Your ADHD symptoms still score at least 28 on that same rating scale at the baseline visit.
- A doctor has rated your ADHD as at least moderately severe (a score of 4 or higher) on a standard clinical scale at the baseline visit.
Who may not be able to join:
- You are pregnant (based on a positive pregnancy test at the baseline visit).
- You have been diagnosed with any of the following conditions: Tourette's disorder, panic disorder, conduct disorder, a psychotic disorder, post-traumatic stress disorder (PTSD), or bipolar disorder.
- You have generalised anxiety disorder that requires medication to treat.
- You have been diagnosed with autism spectrum disorder.
- Your main focus of treatment is a personality disorder, oppositional defiant disorder, or obsessive-compulsive disorder (OCD).
- You have been diagnosed with major depression and are currently in a depressive episode, have needed treatment for it in the past 3 months, or a doctor thinks your depression may get worse during the trial.
- You have an intellectual disability with an IQ score below 70.
- You are considered to have a significant risk of suicide, including if you have had certain suicidal thoughts or behaviour in the past 6 months (as measured by a standard safety questionnaire).
- You have been diagnosed with a substance use disorder.
- Your blood test results fall outside acceptable ranges, including low platelet count, low haemoglobin, low neutrophil count, abnormal liver enzyme levels, reduced kidney function, high muscle enzyme levels (with some exceptions — confirm with trial site), or abnormal thyroid test results.
- You are unable or unwilling to stop taking certain medications that are not allowed during the trial, such as ADHD medications or antidepressants.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Nobuhito Sanada, Otsuka Pharmaceutical Co., Ltd.
Phone: +81-3-6361-7314
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change from baseline in ADHD-RS-5 symptom total raw score at Week 6.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.